• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Market news: Britain will provide more defensive military assistance to Saudi Arabia.Market news: Ukraine claims to have attacked Russias Kubyshev oil refinery.Saudi Arabia, Egypt, Türkiye, and Pakistan held a quadrilateral meeting in New York on September 22 local time.On September 22nd, RSM UK analyst Thomas Pugh stated that UK net public borrowing in August rose sharply compared to the same period last year, meaning the upcoming budget will be more challenging than anticipated by new Prime Minister Andy Burnham or Chancellor of the Exchequer John Healy when they took office months ago. A new round of tax increases seems inevitable in October. Cumulative borrowing so far this fiscal year has reached £77.3 billion, far exceeding the £69.2 billion previously predicted by the budget oversight body, the OBR. Given rising inflation and the potential for increased spending in the budget, borrowing is expected to continue to significantly exceed expectations. However, with UK government bond yields high, investors are closely watching every borrowing figure for clues about the governments seriousness regarding fiscal discipline.On September 22, Novo Nordisk CEO Mike Dustdale stated that the company must take more steps to rebuild investor confidence, given that its flagship drugs, such as Ozempic, will face patent expirations early in the next decade. Dustdale said, "What weve learned over the past few years is that over-promising and under-delivering quickly erode trust." Investors "want to know whats next." Novo Nordisks stock price fell on Monday as investors were disappointed by the lack of detail in its turnaround plan during the companys Capital Markets Day. Novo Nordisk is facing patent expirations for Ozempic and Wegovy in the US and Europe, a product portfolio that currently accounts for about three-quarters of its sales. Novo Nordisk has pledged to launch more than five blockbuster drugs by 2030 and achieve more than $23 billion in new sales by 2035. These goals are widely considered to be in line with investor expectations. BMO Capital Markets analysts stated that Novo Nordisk is still in a phase where it needs to prove itself with results. Investors need a clearer understanding of the companys next-generation drugs and their potential market acceptance in order to rebuild confidence.

Gold Falls Below $1,900; The dollar Soars As The Fed Prepares to Double Its Rate Hikes

Charlie Brooks

Apr 26, 2022 09:57

G2.png


On Monday's session on the New York Comex, an ounce of the yellow gold returned to the $1,800 level.


This came as the dollar strengthened on expectations that the Federal Reserve would hike rates by 50 basis points, or half a percentage point, at its May policy meeting next week — more than double the 25 basis points, or quarter point, approved in March, the first increase in the post-pandemic era in the United States.


On Monday, Comex front-month gold futures for June finished down $38.30, or 2%, at $1,896 an ounce. On April 18, June gold reached a six-week high of $2,003 on concerns that the US could enter recession as a result of strong Fed attempts to rein down inflation. Gold is frequently used as a hedge against economic and political uncertainty.


Over the last week, a series of Fed speakers assuaged market concerns that the economy would turn negative as a result of the central bank's efforts to contain price pressures developing at their highest rate in 40 years.


While fears of a hard landing have not completely vanished, optimism, particularly regarding the sterling job market, has won over some pessimists. This has resulted in the dollar surging – the primary beneficiary of a rate hike — at the expense of gold and other safe-haven assets.


The Dollar Index, which compares the US currency to six main rivals, touched a 25-month high of 101.745 on Monday.


US bond yields, which frequently move in lockstep with the dollar, have recently decoupled from the greenback. The yield on the US 10-year Treasury note fell for the third consecutive day, dropping about 4% on the day.


While risk aversion across the board drew investors to safe-haven assets, gold's near-term charts showed the possibility of a rebound to the $1,900 lows, at the very least, following the week's loss of more than $100. 


"Gold has begun to exhibit oversold conditions on a daily basis, which may result in a short-term relief rally, albeit not necessarily a reversal," Dixit explained. "The $1,925 to $1,935 level remains a hurdle, but a rebound is probable." If history is any guide, gold will almost certainly find buyers at lower prices."


On the other hand, he noted, a Comex settlement below $1,888 will exacerbate gold's troubles.